Prevention of Autoimmune Diabetes by Linomide in Nonobese Diabetic (NOD) Mice Is Associated with Up-Regulation of the TCR-Mediated Activation of p21ras

Journal of Immunology

Volumn 157, Issue 10, 1996, Pages 4721-4725

  Rapoport, Micha J ^a,c   Weiss, Lola ^b   Mor, Anat ^a   Bistritzer, Tzvy ^a   Ramot, Yoram ^a   Slavin, Shimon ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGICAL ADJUVANT; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN P21; QUINOLINOL DERIVATIVE; ROQUINIMEX;

ANIMAL; ARTICLE; BIOSYNTHESIS; DRUG EFFECT; FEMALE; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DIABETES MELLITUS, TYPE 1; FEMALE; HYDROXYQUINOLINES; MALE; MICE; MICE, INBRED NOD; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTORS, ANTIGEN, T-CELL; UP-REGULATION;

EID: 0030588614     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Castano, L., and G. S. Eisenbarth. 1990. Type-I diabetes: a chronic autoimmune disease of human, mouse and rat. Annu. Rev. Immunol. 8:647.
2. Zipris, D., A. H. Lazarus, A. R. Crow, M. Haddzija, and T. L. Delovitch. 1991. Defective thymic T cell activalion by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice: evidence for thymic T cell anergy that correlates with the onset of insulitis. J. Immunol. 146:3763.
3. Rapoport, M. J., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska, and T. L. Delovitch. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:87.
4. ras activation. J. Exp. Med. 177:1221.
5. Rabinovitch, A. 1994. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 43: 613.
6. Slavin, S., H. Sidi, L. Weiss, E. Rosenman, T. Kalland, and D. Gross. 1993. Prevention of insulin-dependent diabetes mellitus (IDDM) and autoimmune insulitis in NOD mice by linomide, a new immunoregulator of autoimmune diseases. J. Immunol. Immunopharmacol. 13:129.
7. Slavin, S., H. Sidi, L. Weiss, E. Rosenman, T. Kalland, and D. Gross. 1993. Linomide a new treatment for autoimmune diseases: the potential in type 1 diabetes. Diabetes Metab. Rev. 9:311.
8. Gross, D. J., C. H. Sidi, L. Weiss, T. Kalland, E. Rosenman, and S. Slavin. 1994. Prevention of diabetes mellitus in non obese diabetic mice by linomide: a novel immunomodulator drug. Diabetologia 37:1195.
9. Larson, E. T. 1987. The mechanisms of action of the new immunomodulator LS2616 on T cell responses. Int. J. Immunopharmacol. 9:425.
10. Graves, J. D., S. C. Lucas, D. R. Alexander, and D. A. Cantrell. 1990. Guanosine nucleotide regulation of inositol phospholipid hydrolysis and CD3-antigen phosphorylation in permeabilized T lymphocytes. Biochem. J. 265:407.
11. ras. Mol. Cell. Biol. 12:3305.
12. ras upon T-cell activation. Nature 346:719.
13. Kalland, T., G. Alm, and T. Stalhandshe. 1985. Augmentation of mouse natural killer cell activity by LS2616, a new immunomodulator. J. Immunol. 134:3956.
14. Wanders, E., E. Larsson, B. Gerdin, and G. Tufeson 1989. Abolition of the effect of cyclosporine on rat cardiac allograft rejection by the new imunomodulator LS2616 (linomide). Transplantation 47:216.
15. Kaplan, D. R., D. K. Morrison, G. Wong, F. McCormick, and L. T. Williams. 1990. PDF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell 61:125.
16. Ellis, C., M. Moran, F. McCormick, and T. Pawson. 1990. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature 343:377.
17. Grand, R. J., and Owen D. 1991. The biochemistry of ras p21. Biochem. J. 279:609.
18. Warne, P. H., P. R. Viciana, and J. Downward. 1993. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364:342.
19. ras during T-cell activation and growth. Immunol. Today 16:159.
20. Pawson, T. 1995. Protein modules and signaling networks. Nature 373:573.
21. Satoh, T., M. Nakafuku, A. Miayjima, and Y. Kaziro. 1991. Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colon-stimulating factor, but not from interleukin 4 Proc. Natl. Acad. Sci. USA 88:3314.
22. Rapoport, M. J., A. Mor, T. Bistritzer, Y. Ramot, O. Levi, S. Slavin, and A. J. Wysenbeek. 1996. Protooncogenes and autoimmunity. Isr. J. Med. Sci. In press.